Why GLP-1 Medications Are Part of Fertility Conversations GLP-1 receptor agonists such as semaglutide were originally developed to treat type 2 diabetes
Enhances Insulin Secretion: By stimulating the pancreas, it helps in the release of more insulin, aiding in the efficient metabolism of sugar
These drugs, initially developed for diabetes, have demonstrated significant weight loss benefits, positioning them as key players in the fight against obesity
This is mainly due to the rapid weight loss or hormonal imbalance which alters ovulation and hence the menstrual cycle
Tirzepatides additional GIP pathway may enhance insulin sensitivity and fat metabolism, though the exact mechanism is still being studied
It does not provide an individualized diagnosis, medication recommendation, or treatment plan